Evidence map›Paper›PMID 21848289›Full record

ArticleBiochemistry2011

Designed hairpin peptides interfere with amyloidogenesis pathways: fibril formation and cytotoxicity inhibition, interception of the preamyloid state.

Kelly N L Huggins, Marco Bisaglia, Luigi Bubacco, Marianna Tatarek-Nossol, Aphrodite Kapurniotu, Niels H Andersen

Abstract read
In one paragraph

Article in Biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Modulating the Amyloidogenesis of α-Synuclein.Current neuropharmacology · 2016
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Kelly N L HugginsDepartment of Chemistry, University of Washington, Seattle, Washington 98195, USA.
Marco Bisaglia
Luigi Bubacco
Marianna Tatarek-Nossol
Aphrodite Kapurniotu
Niels H Andersen
Technical University of Munich · DEUniversity of Padua · ITUniversity of Washington · US

Funding

THERMODYNAMICS AND THE DESIGN OF STRUCTURED PEPTIDESR01GM059658 · NIGMS · UNIVERSITY OF WASHINGTON · PI ANDERSEN, NIELS HJORTH · 2000 to 2009
$1.9M
NIGMS NIH HHS 3R01-GM059658-08S1NIGMS NIH HHS R01 GM059658
6 · The paper itself

Abstract

Hairpin peptides bearing cross-strand Trp-Trp and Tyr-Tyr pairs at non-H-bonded strand sites modulate the aggregation of two unrelated amyloidogenic systems, human pancreatic amylin (hAM) and α-synuclein (α-syn), associated with type II diabetes and Parkinson's disease, respectively. In the case of hAM, we have previously reported that inhibition of amyloidogenesis is observed as an increase in the lag time to amyloid formation and a diminished thioflavin (ThT) fluorescence response. In this study, a reduced level of hAM fibril formation is confirmed by transmission electron microscopy imaging. Several of the hairpins tested were significantly more effective inhibitors than rat amylin. Moreover, a marked inhibitory effect on hAM-associated cytotoxicity by the more potent hairpin peptide is demonstrated. In the case of α-syn, the dominant effect of active hairpins was, besides a weakened ThT fluorescence response, the earlier appearance of insoluble aggregates that do not display amyloid characteristics with the few fibrils observed having abnormal morphology. We attribute the alteration of the α-synuclein aggregation pathway observed to the capture of a preamyloid state and diversion to nonamyloidogenic aggregates. These β-hairpins represent a new class of amyloid inhibitors that bear no sequence similarity to the amyloid-producing polypeptides that are inhibited. A mechanistic rationale for these effects is proposed.

Indexed as

alpha-SynucleinAmino Acid SequenceAmyloidAnimalsBenzothiazolesDrug DesignHumansIn Vitro TechniquesIslet Amyloid PolypeptideMicroscopy, Electron, TransmissionModels, BiologicalModels, MolecularMolecular Sequence DataPeptidesProtein FoldingProtein Multimerizationalpha-SynucleinAmyloidBenzothiazolesIslet Amyloid PolypeptidePeptidesRecombinant ProteinsThiazolesthioflavin T

Identifiers

PMID21848289
PMCPMC3177973
OpenAlexW2331980872

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.